Products for Research Use Only
RegisterLogin

E (c (RGDfK) ) 2

CAT: 0804-HY-P5098-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P5098-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
E (c (RGDfK) ) is an αvβ3 integrin-specific binding moiety with tumor targeting properties. Increased uptake of E (c (RGDfK) ) in human ovarian cancer OVCAR-3 xenograft tumors may be useful in cancer research[1].
CAS Number
250612-47-6
UNSPSC
12352209
Target
Integrin
Type
Peptides
Related Pathways
Cytoskeleton
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/e-c-rgdfk.html
Purity
99.82
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N1)=O)CC(O)=O)=O)=O)CCCNC(N)=N)=O)CCCCNC([C@@H](N)CCC(NCCCC[C@@H]2NC([C@H](NC([C@@H](NC(CNC([C@@H](NC2=O)CCCNC(N)=N)=O)=O)CC(O)=O)=O)CC3=CC=CC=C3)=O)=O)=O)[C@H]1CC4=CC=CC=C4
Molecular Formula
C59H87N19O16
Molecular Weight
1318.44
References & Citations
[1]Polyak D, et al. Development of PEGylated doxorubicin‐E‐[c (RGDfK) 2] conjugate for integrin‐targeted cancer therapy[J]. Polymers for Advanced Technologies, 2011, 22 (1) : 103-113.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P0023-01Cyclo (-RGDfK)
HY-P11428DBCO-cyclo (RGDfK)
HY-P10732-01DOTA-cyclo (RGDfK)
HY-P4047-01Cyclo (RGDfK (Mal) )
HY-P0023A-01Cyclo (-RGDfK) (TFA)
HY-W068035-01(E, E) -2,4-Hexadienal
HY-4031885' (E) -VP-2'-OMe-Bz-C Phosphoramidite
HY-121683-01(E) -2-Hexadecenal
HY-121582-01(E) -SI-2
HY-N3149-01(E) -2-Hydroxycinnamaldehyde

Alternative Products

CatalogName
A8164-25Cyclo (-RGDfK)
BINK-055Acrylylated -RGDfK
MBS2569822-01c(RGDfK)
GTR19178334C (RGDfK)
B2363-5Cyclo（RGDfK）
GTR19157085-01Cyclo (RGDfK)
MBS3611707-01Cyclo(RGDfK)
M22892-01Cyclo (-RGDfK) TFA

Popular Products